EcoDrugPlus

Glutamate Receptor 1

Ensembl ID : ENSLCRG00005023318
Gene Symbol: LOC104931884
2 Cross references
249 Possible Orthologues:

Glutamate Receptor 2-Like

Ensembl ID : ENSLCRG00005021303
Gene Symbol: LOC104936473
3 Cross references
242 Possible Orthologues:

Glutamate Receptor 3

Ensembl ID : ENSLCRG00005016213
Gene Symbol: LOC104919730
3 Cross references
251 Possible Orthologues:

Glutamate Receptor Ionotropic, Nmda 1-Like

Ensembl ID : ENSLCRG00005003190
Gene Symbol: LOC113745469
2 Cross references
167 Possible Orthologues:

Glutamate Receptor Ionotropic, Nmda 3b

Ensembl ID : ENSLCRG00005021948
Gene Symbol: LOC104920054
2 Cross references
226 Possible Orthologues:

Glutamate Receptor, Ionotropic, Ampa 1a

Ensembl ID : ENSLCRG00005001255
Gene Symbol: GRIA1A
3 Cross references
251 Possible Orthologues:

Glutamate Receptor, Ionotropic, Ampa 2b

Ensembl ID : ENSLCRG00005019791
Gene Symbol: GRIA2B
3 Cross references
224 Possible Orthologues:

Glutamate Receptor, Ionotropic, Ampa 4b

Ensembl ID : ENSLCRG00005002153
Gene Symbol: GRIA4B
3 Cross references
249 Possible Orthologues:

Glutamate Receptor, Ionotropic, N-Methyl D-Aspartate 1a

Ensembl ID : ENSLCRG00005018540
Gene Symbol: GRIN1A
3 Cross references
205 Possible Orthologues:

Glutamate Receptor, Ionotropic, N-Methyl D-Aspartate 2a, B

Ensembl ID : ENSLCRG00005002595
Gene Symbol: GRIN2AB
2 Cross references
98 Possible Orthologues:

Glutamate Receptor, Ionotropic, N-Methyl D-Aspartate 2b, Genome Duplicate B

Ensembl ID : ENSLCRG00005009992
Gene Symbol: GRIN2BB
3 Cross references
250 Possible Orthologues:

Glutamate Receptor, Ionotropic, N-Methyl D-Aspartate 2d, A

Ensembl ID : ENSLCRG00005023910
Gene Symbol: GRIN2DA
2 Cross references
214 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).